The Protein Tyrosine Phosphatase Nonreceptor 22 (PTPN22) Is Associated With High GAD Antibody Titer in Latent Autoimmune Diabetes in Adults
Open Access
- 1 March 2008
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 31 (3), 534-538
- https://doi.org/10.2337/dc07-1457
Abstract
OBJECTIVE—We previously demonstrated the presence of two different populations among individuals with adult-onset autoimmune diabetes: those having either a high titer or a low titer of antibodies to GAD (GADAs). Protein tyrosine phosphatase nonreceptor type 22 (PTPN22) has been identified as a new susceptibility gene for type 1 diabetes and other autoimmune diseases. The aim of the present study was to evaluate whether the phenotypic heterogeneity of adult-onset autoimmune diabetes based on the GADA titer is associated with the PTPN22 C1858T polymorphism. RESEARCH DESIGN AND METHODS—Analysis for the C1858T polymorphism using the TaqMan assay was performed in 250 subjects with adult-onset autoimmune diabetes, divided into two subgroups with low (≤32 arbitrary units) or high (>32 arbitrary units) GADA titers and 450 subjects with classic type 2 diabetes (from the Non Insulin Requiring Autoimmune Diabetes [NIRAD] Study cohort of 5,330 subjects with adult-onset diabetes) and in 558 subjects with juvenile-onset type 1 diabetes and 545 normoglycemic subjects. RESULTS—Genotype, allele, and phenotype distributions of the PTPN22 C1858T variant revealed similar frequencies in autoimmune diabetes with high GADA titer and juvenile-onset type 1 diabetes. An increase in TT and CT genotypes was observed in individuals with a high GADA titer compared with a low GADA titer, those with type 2 diabetes, and control subjects (P < 0.002 for all comparisons). The PTPN22 1858T allele and phenotype frequencies were increased in high GADA titer compared with a low GADA titer, type 2 diabetic, and control subjects (P < 0.001 for all comparisons, odds ratio 2.6). CONCLUSIONS—In adult-onset autoimmune diabetes, the PTPN22 1858T variant is associated only with a high GADA titer, providing evidence of a genetic background to clinical heterogeneity identified by GADA titer.Keywords
This publication has 24 references indexed in Scilit:
- High Titer of Autoantibodies to GAD Identifies a Specific Phenotype of Adult-Onset Autoimmune DiabetesDiabetes Care, 2007
- The PTPN22 C1858T functional polymorphism and autoimmune diseases--a meta-analysisRheumatology, 2006
- Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variantNature Genetics, 2005
- Analysis of Families in the Multiple Autoimmune Disease Genetics Consortium (MADGC) Collection: the PTPN22 620W Allele Associates with Multiple Autoimmune PhenotypesAmerican Journal of Human Genetics, 2005
- Genetic Association of the R620W Polymorphism of Protein Tyrosine Phosphatase PTPN22 with Human SLEAmerican Journal of Human Genetics, 2004
- A Missense Single-Nucleotide Polymorphism in a Gene Encoding a Protein Tyrosine Phosphatase (PTPN22) Is Associated with Rheumatoid ArthritisAmerican Journal of Human Genetics, 2004
- A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetesNature Genetics, 2004
- Genetic prediction of type 1 diabetes in a population with low frequency of HLA risk genotypes and low incidence of the disease (the DIABFIN study)Diabetes/Metabolism Research and Reviews, 2004
- Environmental risk factors for type 1 diabetes in Rome and provinceArchives of Disease in Childhood, 2003
- T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteinsNature, 1990